The US Food and Drug Administration has approved an ingestible digital
sensor that can be swallowed in a pill to track health data from inside the
body. The idea is that the data can be used not only by patients themselves, but
also by caregivers and doctors to individualize their care.
The ingestible sensor, formerly known as the Ingestion Event Marker or IEM, is already approved for use in Europe.
It is the first "digital pill" to receive FDA approval, in a move that its maker Proteus Digital Health, whose headquarters are in Redwood City, California, sees as the start of a era where digital medicine "shifts the care paradigm".
http://www.medicalnewstoday.com/articles/248557.php
The ingestible sensor, formerly known as the Ingestion Event Marker or IEM, is already approved for use in Europe.
It is the first "digital pill" to receive FDA approval, in a move that its maker Proteus Digital Health, whose headquarters are in Redwood City, California, sees as the start of a era where digital medicine "shifts the care paradigm".
http://www.medicalnewstoday.com/articles/248557.php
No comments:
Post a Comment